A study published in the New England Journal of Medicine, Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma, has suggested that although most children with persistent asthma improve as they get older, longitudinal measurements of growth and decline in lung function have revealed links between asthma and subsequent chronic airflow obstruction.
Seven hundred children in a Childhood Asthma Management Program who were between the ages of 5 and 12 took part in the study and they were followed until they were at least 23.
At the end of the study, 11% of the young adults suffered from Chronic Obstructive Pulmonary Disorder (COPD). Other than persistent asthma, risks for COPD included being male and having poor lung function at the start of the study. And by the time children with persistent asthma reached early adulthood, 75% showed an early decline in lung function or reduced lung growth.
POWERbreathe is an Inspiratory Muscle Training device (IMT) which means it trains the muscles used to breathe in, your inspiratory muscles, and inspiratory muscle training has been shown to relieve the symptoms of asthma by improving lung function, resulting in reduction of medication and a fall in hospitalisations.
POWERbreathe IMT may be used by children over the age of 7 (the Plus is more comfortable for children) who are old enough to understand how to effectively perform the breathing exercises under the supervision of an adult. And because POWERbreathe IMT is drug-free it won't interfere with asthma medication. Always check with your GP first before undertaking any form of training.
In summary, IMT was shown to generate:
- A reduction in the consumption of asthma medication of up to 79%
- A reduction of ß2-agonists consumption by up to 79%
- An improvement in asthma symptoms by up to 75% in 3 weeks